-
To Understand Disparities, Look at the Broader Contexts
Researchers at the AACR Annual Meeting 2024 consider ways in which social and economic factors like location affect cancer risk and outcomes.
by Eric Fitzsimmons
-
Regular Aspirin Use May Help Fight Colorectal Cancer
Aspirin appears to activate an immune response against colorectal cancer in the early stages of the disease.
by Sandra Gordon
-
Progress Against Cancer
New research fuels progress in cancer survival, prevention and side effect management.
-
Vaccines Spark Activity in Pancreatic Cancer
Scientists thought pancreatic cancer wouldn’t respond to immunotherapy. Now research has found vaccines can trigger the immune system to fight the disease.
by Thomas Celona
-
Lifestyle Choices and Cancer
What people eat and drink and their level of physical activity can affect their risk of having cancer. New interventions aim to reduce risk factors.
by Kevin McLaughlin
-
Forward Look
Improving Colorectal Cancer Screening OptionsTests currently in development seek to offer greater accuracy and reach more people.
by Eric Fitzsimmons
-
Endometrial Cancer and Screening for Lynch Syndrome
AACR highlights team research that led to Lynch syndrome testing for all people with endometrial cancer in the U.K.
by Marci A. Landsmann
-
Improving Glioblastoma Treatment
Phase I clinical trial finds adding a radiosensitizer may improve radiation’s ability to kill this fast-growing brain cancer.
by Thomas Celona
-
Quality of Life Across the Lifespan
As more people diagnosed with and treated for cancer live years beyond treatment, researchers look for ways to improve quality of life.
by Kevin McLaughlin
-
Results That Matter
Cancer medications granted accelerated approval are often confirmed despite not demonstrating a benefit in overall survival or quality of life.
by Eric Fitzsimmons
Cancer Talk
Treatment Lags Behind Guidelines for Many Men With Prostate Cancer
Guidelines for treating advanced prostate cancer changed in 2017, but a recent study indicated many patients were not being treated accordingly.
by Laura Gesualdi-Gilmore
Treating HER2-ultralow Breast CancerFDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.
by Sandra Gordon
Lessons Learned as a Caregiver and PatientAfter caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.
by Miriam Díaz-Gilbert
Screening Options for People With Dense BreastsReports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker